The raised guidance and expanding margins (Adjusted EBITDA margin 48%) reinforce the durable growth narrative. Traders should watch for continued HSA account growth and custodial revenue trends in the second half, as the company enters a seasonally stronger period. The $948.4M remaining buyback authorization provides downside support.
Price Chart
Executive Summary
HealthEquity reported Q2 FY2027 revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, beating consensus estimates of $349.2M and $1.19 respectively. The company raised its full-year revenue guidance to $1.411B-$1.421B and non-GAAP EPS to $4.66-$4.73, driven by record HSA accounts (10.7M) and assets ($37.9B), with Adjusted EBITDA margin expanding to 48%. The beat and raised guidance signal strong operational momentum and durable growth in the HSA business.
Key Financial Metrics
Key Facts
- Revenue of $350.7M (+8% YoY) beat consensus of $349.2M
- Non-GAAP EPS of $1.24 beat consensus of $1.19 by 4.2%
- GAAP net income of $65.6M (+10% YoY), GAAP diluted EPS $0.78 (+15% YoY)
- Adjusted EBITDA of $167.0M (+11% YoY), margin expanded to 48% from 46%
- Total HSA Assets grew 14% to $37.9B; HSA accounts up 8% to 10.7M
- Raised FY2027 guidance: revenue $1.411B-$1.421B, non-GAAP EPS $4.66-$4.73
- Repurchased 1.2M shares for $108.1M in Q2; $948.4M remaining authorization
- Record HSA accounts of 10.7M and record HSA Assets of nearly $38B
Financial Impact
Revenue beat by $1.5M (+0.4%), EPS beat by $0.05 (+4.2%), guidance raised by ~$10M at midpoint
Risk Factors
- Dependence on tax-advantaged HSA regulations which could change
- Interest rate sensitivity on HSA cash yields and custodial revenue
- Integration risks from future acquisitions or portfolio purchases
- Competition from larger financial and benefits administration firms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3351951 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 27, 2026 5w ago | 8-K | $93.39 $88.60 | ▼ −5.13% | ▼ −4.62% | $90.04 (−3.59%) |
Aug 27, 2026 5w ago | Press Release | $93.39 $88.60 | ▼ −5.13% | ▼ −4.62% | $90.04 (−3.59%) |
Aug 3, 2026 8w ago | Press Release | $104.97 $97.00 | ▼ −7.59% | ▼ −6.35% | $90.04 (−14.22%) |
Jun 2, 2026 17w ago | Insider Cluster | $85.21 $95.31 | ▲ +11.85% | ▲ +12.85% | $90.04 (+5.67%) |
May 28, 2026 18w ago | 8-K | $87.99 $87.81 | ▼ −0.20% | ▲ +1.59% | $90.04 (+2.33%) |
May 28, 2026 18w ago | Press Release | $87.99 $87.81 | ▼ −0.20% | ▲ +1.59% | $90.04 (+2.33%) |
May 8, 2026 21w ago | 8-K | $81.65 $89.23 | ▲ +9.28% | ▲ +9.59% | $90.04 (+10.28%) |
Mar 17, 2026 28w ago | Press Release | $79.57 $84.53 | ▲ +6.23% | ▲ +0.19% | $90.04 (+13.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access